Capstone Wealth Management Group, Inc.’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Buy
+3,449
New +$593K 0.4% 57

Other funds holding IBB

Capstone Wealth Management Group, Inc.'s IBB Position: Q2 2026 in Review

Capstone Wealth Management Group, Inc. opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 3,449 shares worth $656K. The stake represents 0.4% of the portfolio and ranks #57 among its holdings.

354 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Capstone Wealth Management Group, Inc. held 3,449 shares of iShares Biotechnology ETF worth $656K as of Q2 2026.
  • iShares Biotechnology ETF was a new Capstone Wealth Management Group, Inc. position in Q2 2026.
  • iShares Biotechnology ETF made up 0.4% of Capstone Wealth Management Group, Inc.'s portfolio in Q2 2026, its #57 holding.
  • 354 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Capstone Wealth Management Group, Inc.'s 13F filing for Q2 2026, filed 27 Jul 2026.